Cytarabine-daunorubicin, also known as CPX-351, is a liposomal formulation that synergistically combines cytarabine and daunorubicin in a 5:1 ratio. This targeted delivery system enhances the concentration of both compounds in leukemia cells while minimizing exposure to normal bone marrow cells. It is utilized in research focused on leukemia treatment and mechanisms, making it a valuable tool for investigating therapeutic strategies and drug efficacy in hematological malignancies.
Cytarabine-daunorubicin, also known as CPX-351, is a liposomal formulation that synergistically combines cytarabine and daunorubicin in a 5:1 ratio. This targeted delivery system enhances the concentration of both compounds in leukemia cells while minimizing exposure to normal bone marrow cells. It is utilized in research focused on leukemia treatment and mechanisms, making it a valuable tool for investigating therapeutic strategies and drug efficacy in hematological malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
